Prevention of calcification of glutaraldehyde pretreated bovine pericardium through controlled release polymeric implants: studies of Fe3+, Al3+, protamine sulphate and levamisole
- 1 November 1990
- journal article
- research article
- Published by Elsevier in Biomaterials
- Vol. 11 (9) , 718-723
- https://doi.org/10.1016/0142-9612(90)90034-n
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Controlled-Release Drug Delivery of Diphosphonates to Inhibit Bioprosthetic Heart Valve Calcification: Release Rate Modulation with Silicone Matrices Via Drug Solubility and Membrane CoatingJournal of Pharmaceutical Sciences, 1987
- NATURE AND PROPERTIES OF CARDIOVASCULAR DEPOSITS1987
- The effect of aluminum on the rate of dissolution of calcium hydroxyapatite—A contribution to the understanding of aluminum-induced bone diseasesCalcified Tissue International, 1985
- ONSET AND PROGRESSION OF EXPERIMENTAL BIOPROSTHETIC HEART-VALVE CALCIFICATION1985
- BIOLOGIC DETERMINANTS OF DYSTROPHIC CALCIFICATION AND OSTEOCALCIN DEPOSITION IN GLUTARALDEHYDE-PRESERVED PORCINE AORTIC-VALVE LEAFLETS IMPLANTED SUBCUTANEOUSLY IN RATS1983
- STEREOSPECIFIC INHIBITION OF ALKALINE-PHOSPHATASE BY L-TETRAMISOLE PREVENTS INVITRO CARTILAGE CALCIFICATION1980
- Interaction of Alkaline Phosphatase of E. coli with Metal Ions and Chelating Agents*Biochemistry, 1962
- PROTEIN MEASUREMENT WITH THE FOLIN PHENOL REAGENTJournal of Biological Chemistry, 1951